LABS Stock Overview

Distributes medical devices in Indonesia. More details

LABS fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	2/6
Dividends	0/6

Rewards

Revenue grew by 46.5% over the past year

Risk Analysis

Interest payments are not well covered by earnings

High level of non-cash earnings

Profit margins (1.6%) are lower than last year (3%)

Does not have a meaningful market cap (IDR541B)

My Notes

Capture your thoughts, links and company narrative

PT UBC Medical Indonesia Tbk Competitors

PT. Penta Valent

IDX:PEVE

Rp508.5b

Itama Ranoraya

IDX:IRRA

Rp603.1b

Multi Medika Internasional

IDX:MMIX

Rp312.0b

Millennium Pharmacon International

IDX:SDPC

Rp168.2b

Price History & Performance

Summary of share price highs, lows and changes for UBC Medical Indonesia
Historical stock prices
Current Share Price	Rp137.00
52 Week High	Rp228.00
52 Week Low	Rp109.00
Beta	0
1 Month Change	3.79%
3 Month Change	-4.20%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	0%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	LABS	ID Healthcare	ID Market
7D	0.7%	4.6%	0.6%
1Y	n/a	20.1%	3.0%

Return vs Industry: Insufficient data to determine how LABS performed against the ID Healthcare industry.

Return vs Market: Insufficient data to determine how LABS performed against the ID Market.

Price Volatility

Is LABS's price volatile compared to industry and market?
LABS volatility
LABS Average Weekly Movement	3.5%
Healthcare Industry Average Movement	5.1%
Market Average Movement	5.5%
10% most volatile stocks in ID Market	13.0%
10% least volatile stocks in ID Market	2.4%

Stable Share Price: LABS has not had significant price volatility in the past 3 months compared to the ID market.

Volatility Over Time: Insufficient data to determine LABS's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2014	64	Franciscus Yoshua Raintjung	www.ubcindonesia.com

PT UBC Medical Indonesia Tbk distributes medical devices in Indonesia. It operates in two segments, Medical Disposables and Consumables, and Diagnostics and Equipment. The company offers next generation molecular, retina AI, infectious disease, HPV DNA test, real time PCR, TB management, and newborn screening products.

PT UBC Medical Indonesia Tbk Fundamentals Summary

How do UBC Medical Indonesia's earnings and revenue compare to its market cap?
LABS fundamental statistics
Market cap	Rp541.15b
Earnings (TTM)	Rp2.19b
Revenue (TTM)	Rp136.70b

247.2x

P/E Ratio

4.0x

P/S Ratio

Is LABS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LABS income statement (TTM)
Revenue	Rp136.70b
Cost of Revenue	Rp82.14b
Gross Profit	Rp54.56b
Other Expenses	Rp52.37b
Earnings	Rp2.19b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	0.55
Gross Margin	39.92%
Net Profit Margin	1.60%
Debt/Equity Ratio	82.8%

How did LABS perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/30 18:55
End of Day Share Price	2024/12/27 00:00
Earnings	2023/12/31
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PT UBC Medical Indonesia Tbk is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution